Ablation of the androgen receptor from vascular smooth muscle cells demonstrates a role for testosterone in vascular calcification

Scientific Reports

Volumn 6, Issue , 2016, Pages

  Zhu, Dongxing ^a   Hadoke, Patrick W F ^b   Wu, Junxi ^b,c   Vesey, Alex T ^b   Lerman, Daniel A ^d,e   Dweck, Marc R ^b   Newby, David E ^b   Smith, Lee B ^c   MacRae, Vicky E ^a  

^a UNIVERSITY OF EDINBURGH   (United Kingdom)

^b UNIVERSITY OF EDINBURGH   (United Kingdom)

^c UNIVERSITY OF EDINBURGH   (United Kingdom)

^d UNIVERSITY OF EDINBURGH   (United Kingdom)

^e ROYAL INFIRMARY OF EDINBURGH   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ANDROGEN RECEPTOR; TESTOSTERONE;

ANIMAL; APOPTOSIS; BLOOD VESSEL CALCIFICATION; BONE DEVELOPMENT; DRUG EFFECTS; GENE EXPRESSION REGULATION; GENETICS; HUMAN; METABOLISM; MOUSE; PATHOLOGY; SMOOTH MUSCLE CELL; VASCULAR SMOOTH MUSCLE;

ANIMALS; APOPTOSIS; GENE EXPRESSION REGULATION; HUMANS; MICE; MUSCLE, SMOOTH, VASCULAR; MYOCYTES, SMOOTH MUSCLE; OSTEOGENESIS; RECEPTORS, ANDROGEN; TESTOSTERONE; VASCULAR CALCIFICATION;

EID: 84964636334     PISSN: None     EISSN: 20452322     Source Type: Journal    
DOI: 10.1038/srep24807     Document Type: Article

References (50)

1. Sullivan, M. L., Martinez, C. M., Gennis, P. & Gallagher, E. J. The cardiac toxicity of anabolic steroids. Prog Cardiovasc Dis. 41, 1-15 (1998).
2. Jeppesen, L. L. et al. Decreased serum testosterone in men with acute ischemic stroke. Arterioscler Thromb Vasc Biol. 16, 749-754 (1996).
3. Simon, D. et al. Association between plasma total testosterone and cardiovascular risk factors in healthy adult men: The Telecom Study. J Clin Endocrinol Metab. 82, 682-685 (1997).
4. Stellato, R. K., Feldman, H. A., Hamdy, O., Horton, E. S. & McKinlay, J. B. Testosterone, sex hormone-binding globulin, and the development of type 2 diabetes in middle-aged men: prospective results from the Massachusetts male aging study. Diabetes Care. 23, 490-494 (2000).
5. Fogari, R. et al. Serum testosterone levels and arterial blood pressure in the elderly. Hypertens Res. 28, 625-630 (2005).
6. Shores, M. M., Matsumoto, A. M., Sloan, K. L. & Kivlahan, D. R. Low serum testosterone and mortality in male veterans. Arch Intern Med. 166, 1660-1665 (2006).
7. Gan, E. H., Pattman, S., H. S. Pearce, S. & Quinton, R. A UK epidemic of testosterone prescribing, 2001-2010. Clin Endocrinol (Oxf). 79, 564-570 (2013).
8. Baillargeon, J. et al. Risk of Myocardial Infarction in Older Men Receiving Testosterone Therapy. Ann Pharmacother. 48, 1138-1144 (2014).
9. Handelsman, D. J. Testosterone: use, misuse and abuse. Med J Aust. 185, 436-439 (2006).
10. Kanayama, G., Hudson, J. I. & Pope, H. G. Jr. Illicit anabolic-androgenic steroid use. Horm Behav. 58, 111-121(2010).
11. Mangelsdorf, D. J. et al. The nuclear receptor superfamily: the second decade. Cell. 83, 835-839 (1995).
12. Heinlein, C. A. & Chang, C. Androgen receptor (AR) coregulators: an overview. Endocr Rev. 23, 175-200 (2002).
13. Liu, P. Y., Christian, R. C., Ruan, M., Miller, V. M. & Fitzpatrick, L. A. Correlating androgen and estrogen steroid receptor expression with coronary calcification and atherosclerosis in men without known coronary artery disease. J Clin Endocrinol Metab. 90, 1041-1046 (2005).
14. Wu, J. et al. Modulation of neointimal lesion formation by endogenous androgens is independent of vascular androgen receptor. Cardiovasc Res. 103, 281-290 (2014).
15. Hanke, H., Lenz, C., Hess, B., Spindler, K. D. & Weidemann, W. Effect of testosterone on plaque development and androgen receptor expression in the arterial vessel wall. Circulation. 103, 1382-1385 (2001).
16. Zitzmann, M. et al. The CAG repeat polymorphism in the androgen receptor gene affects bone density and bone metabolism in healthy males. Clin Endocrinol (Oxf). 55, 649-657 (2001).
17. Nathan, L. et al. Testosterone inhibits early atherogenesis by conversion to estradiol: critical role of aromatase. Proc Natl Acad Sci USA 98, 3589-3593 (2001).
18. Baron, S. et al. Androgen receptor mediates non-genomic activation of phosphatidylinositol 3-OH kinase in androgen-sensitive epithelial cells. J Biol Chem. 279, 14579-14586 (2004).
19. Margolis, J. R. et al. The diagnostic and prognostic significance of coronary artery calcification. A report of 800 cases. Radiology. 137, 609-616 (1980).
20. Schmermund, A. et al. Assessment of coronary calcification by electron-beam computed tomography in symptomatic patients with normal, abnormal or equivocal exercise stress test. Eur Heart J. 21, 1674-1682 (2000).
21. Wayhs, R., Zelinger, A. & Raggi, P. High coronary artery calcium scores pose an extremely elevated risk for hard events. J Am Coll Cardiol. 39, 225-230 (2002).
22. Dweck, M. R., Boon N. A. & Newby D. E. Calcific aortic stenosis: a disease of the valve and the myocardium. J Am Coll Cardiol. 60, 1854-63 (2012).
23. Zhu, D., Mackenzie, N. C., Farquharson, C. & Macrae, V. E. Mechanisms and clinical consequences of vascular calcification. Front Endocrinol (Lausanne). 3, 95 (2012).
24. Shroff, R. C. et al. Dialysis accelerates medial vascular calcification in part by triggering smooth muscle cell apoptosis. Circulation. 118, 1748-57 (2008).
25. Zhu, D., Mackenzie, N. C., Millan, J. L., Farquharson, C. & MacRae, V. E. The appearance and modulation of osteocyte marker expression during calcification of vascular smooth muscle cells. PLoS One. 6, e19595 (2011).
26. Speer, M. Y. et al. Smooth muscle cells give rise to osteochondrogenic precursors and chondrocytes in calcifying arteries. Circ Res. 104, 733-741 (2009).
27. Rutsch, F. et al. Mutations in ENPP1 are associated with idiopathic infantile arterial calcification. Nat Genet. 34, 379-381 (2003).
28. Murshed, M., Harmey, D., Millan, J. L., McKee, M. D. & Karsenty, G. Unique coexpression in osteoblasts of broadly expressed genes accounts for the spatial restriction of ECM mineralization to bone. Genes Dev. 19, 1093-1104 (2005).
29. Allison, M. A. & Wright, C. M. Age and gender are the strongest clinical correlates of prevalent coronary calcification (R1). Int J Cardiol. 98, 325-330 (2005).
30. Vanderschueren, D. et al. Androgens and bone. Endocr Rev. 25, 389-425 (2004).
31. McRobb, L., Handelsman, D. J. & Heather, A. K. Androgen-induced progression of arterial calcification in apolipoprotein E-null mice is uncoupled from plaque growth and lipid levels. Endocrinology. 150, 841-848 (2009).
32. Son, B. K. et al. Androgen receptor-dependent transactivation of growth arrest-specific gene 6 mediates inhibitory effects of testosterone on vascular calcification. J Biol Chem. 285, 7537-7544 (2010).
33. Zhu, D., Mackenzie, N. C., Millan, J. L., Farquharson, C. & Macrae, V. E. Upregulation of IGF2 expression during vascular calcification. J Mol Endocrinol. 52, 77-85 (2014).
34. Zhu, D. et al. BMP-9 regulates the osteoblastic differentiation and calcification of vascular smooth muscle cells through an ALK1 mediated pathway. J Cell Mol Med. 19, 165-174 (2014).
35. Joshi, N. V. et al. 18 F-fluoride positron emission tomography for identification of ruptured and high-risk coronary atherosclerotic plaques: a prospective clinical trial. Lancet. 383, 705-713 (2014).
36. Shanahan, C. M. et al. Medial localization of mineralization-regulating proteins in association with Monckebergs sclerosis: evidence for smooth muscle cell-mediated vascular calcification. Circulation. 100, 2168-2176 (1999).
37. Moe, S. M., Duan, D., Doehle, B. P., ONeill, K. D. & Chen, N. X. Uremia induces the osteoblast differentiation factor Cbfa1 in human blood vessels. Kidney Int. 63, 1003-1011 (2003).
38. Shroff, R. C. et al. Dialysis accelerates medial vascular calcification in part by triggering smooth muscle cell apoptosis. Circulation. 118, 1748-1757 (2008).
39. Lomashvili, K. A., Garg, P., Narisawa, S., Millan, J. L. & ONeill, W. C. Upregulation of alkaline phosphatase and pyrophosphate hydrolysis: potential mechanism for uremic vascular calcification. Kidney Int. 73, 1024-1030 (2008).
40. Santora, L. J. et al. Coronary calcification in body builders using anabolic steroids. Prev Cardiol. 9, 198-201 (2006).
41. Christian, R. C. et al. Prevalence and predictors of coronary artery calcification in women with polycystic ovary syndrome. J Clin Endocrinol Metab. 88, 2562-2568 (2003).
42. Hak, A. E., Westendorp, I. C., Pols, H. A., Hofman, A. & Witteman, J. C. High-dose testosterone is associated with atherosclerosis in postmenopausal women. Maturitas. 56, 153-160 (2007).
43. Kimura N. et al. Immunocytochemical localization of androgen receptor with polyclonal antibody in paraffin-embedded human tissues. J Histochem Cytochem. 41, 671-8 (1993).
44. Welsh, M. et al. Deletion of androgen receptor in the smooth muscle of the seminal vesicles impairs secretory function and alters its responsiveness to exogenous testosterone and estradiol. Endocrinology. 151, 3374-3385 (2010).
45. Clavel, M. A. et al. The complex nature of discordant severe calcified aortic valve disease grading: new insights from combined Doppler echocardiographic and computed tomographic study. J Am Coll Cardiol. 62, 2329-2338 (2013).
46. Clavel, M. A. et al. Impact of aortic valve calcification, as measured by MDCT, on survival in patients with aortic stenosis: results of an international registry study. J Am Coll Cardiol. 64, 1202-1213 (2014).
47. Johnson, K. A., Polewski, M. & Terkeltaub, R. A. Transglutaminase 2 is central to induction of the arterial calcification program by smooth muscle cells. Circ Res. 102, 529-537 (2008).
48. Mackenzie, N. C. et al. MOVAS-1 cell line: a new in vitro model of vascular calcification. Int J Mol Med. 27, 663-668 (2011).
49. Zhu, D., Mackenzie, N. C., Millan, J. L., Farquharson, C. & MacRae, V. E. A protective role for FGF-23 in local defence against disrupted arterial wall integrity? Molecular and Cellular Endocrinology. 372, 1-11 (2013).
50. Guicciardi, M. E. et al. Cellular inhibitor of apoptosis 1 (cIAP-1) degradation by caspase 8 during TNF-related apoptosis-inducing ligand (TRAIL)-induced apoptosis. Exp Cell Res. 317, 107-116 (2011).